GE HealthCare Technologies (GEHC) - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US36266G1076

Medical Imaging, Ultrasound Machines, Patient Monitoring Devices

GE HealthCare Technologies Inc. is a leading healthcare company that develops, manufactures, and markets a wide range of products, services, and digital solutions to help diagnose, treat, and monitor patients worldwide. The company operates through four main segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

The Imaging segment is a key player in the medical imaging industry, offering a broad portfolio of products and solutions, including molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. These innovative solutions enable healthcare professionals to visualize the body in unprecedented detail, helping them to diagnose and treat a wide range of medical conditions.

The Ultrasound segment provides medical devices and solutions for various clinical areas, including radiology, primary care, women's health, cardiovascular, and point of care. The segment's product portfolio includes handheld ultrasound solutions, surgical visualization and guidance products, and more. These solutions help healthcare professionals to screen, diagnose, treat, and monitor patients with various diseases and conditions.

The Patient Care Solutions segment offers a diverse range of medical devices, consumables, services, and digital solutions. The segment's portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. These solutions help healthcare professionals to monitor, diagnose, and treat patients with various medical conditions, improving patient outcomes and reducing healthcare costs.

The Pharmaceutical Diagnostics segment supplies diagnostic agents, including CT, angiography, and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, which are administered to patients prior to diagnostic scans to increase the visibility of tissues or structures during imaging exams. Additionally, the segment offers molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes.

GE HealthCare Technologies Inc. has collaborated with Mass General Brigham on AI projects, demonstrating its commitment to leveraging artificial intelligence to improve healthcare outcomes. With its headquarters in Chicago, Illinois, the company is well-positioned to drive innovation and growth in the healthcare industry.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for GE HealthCare Technologies (GEHC) - Stock & Dividends

GEHC Stock Overview

Market Cap in USD 34,546m
Sector Healthcare
Industry Health Information Services
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 2023-01-04

GEHC Stock Ratings

Growth 5y 50.1
Fundamental 31.8
Dividend 3.20
Rel. Performance vs Sector -1.24
Analysts 4.13/5
Fair Price Momentum 67.51 USD
Fair Price DCF 99.86 USD

GEHC Dividends

Yield 12m 0.15%
Yield on Cost 5y 0.20%
Dividends CAGR 5y 0.00%
Payout Consistency 100.0%

GEHC Growth Ratios

Growth 12m -0.66%
Growth Correlation 12m 32%
Growth Correlation 3m -71%
CAGR 5y 20.25%
CAGR/Mean DD 5y 1.86
Sharpe Ratio 12m -0.20
Alpha vs SP500 12m -28.47
Beta vs SP500 5y weekly 1.02
ValueRay RSI 66.31
Volatility GJR Garch 1y 30.51%
Price / SMA 50 -2.09%
Price / SMA 200 2.7%
Current Volume 5198k
Average Volume 20d 2788k

External Links for GEHC Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of GEHC stocks?
As of June 22, 2024, the stock is trading at USD 79.17 with a total of 5,198,005 shares traded.
Over the past week, the price has changed by +3.50%, over one month by -3.38%, over three months by -13.16% and over the past year by -0.41%.
What are the forecast for GEHC stock price target?
According to ValueRays Forecast Model, GEHC GE HealthCare Technologies will be worth about 74.3 in June 2025. The stock is currently trading at 79.17. This means that the stock has a potential downside of -6.14%.
Issuer Forecast Upside
Wallstreet Target Price 92.7 17.1
Analysts Target Price 88 11.2
ValueRay Target Price 74.3 -6.14